Navigation Links
Gourmetceuticals to Present Data from Four Studies at Experimental Biology 2008
Date:3/26/2008

Poster Presentations Highlight Potential Uses of Gourmetceuticals'

Functional Ingredients GLPH-1(TM) and PPL-240(TM)

BIG HORN, Wyo., March 26 /PRNewswire/ -- Gourmetceuticals, LLC, a company that markets organically derived and scientifically validated ingredients for use in foods and beverages, today announced that multiple studies of Gourmetceuticals' ingredients, GLPH-1, an immune booster, and PPL-240, an antioxidant, will be presented at the Experimental Biology 2008 conference in San Diego, April 5-9, 2008 in the exhibit hall of the San Diego Convention Center. Data will be presented from clinical studies intended to highlight the clinical benefits of GLPH-1 and PPL-240 for use in functional foods and beverages.

Photoprotective Antioxidant PPL-240(TM) Poster Presentation

April 6, 2008, 1:00 - 2:15 p.m., Abstract Title: Polypodium leucotomos extract, PPL-240, prevents solar-induced DNA damage in human peripheral blood mononuclear cells

Poster Title: Apoptosis and Cell Stress (Poster Number: A414)

Immune Booster GLPH-1(TM) Poster Presentations

April 8, 2008, 12:15 - 1:30 p.m., Abstract Title: The presence of an alpha glucomannan polysaccharide, GLPH-1, (IF-S) activates NFkB and p38 in hMDDC

Poster Title: Chemistry and Cell Biology of Natural Products (Poster Number: A466)

April 8, 2008, 12:15 - 1:30 p.m., Abstract Title: IF-S, a phosphorylated alpha glucomannan polysaccharide, GLPH-1, induces functional human dendritic cell maturation

Poster Title: Chemistry and Cell Biology of Natural Products (Poster Number: A465)

April 8, 2008, 1:45 - 2:45 p.m., Abstract Title: Experimental animal model study of diet supplementation with phosphorylated alpha glucomannan polysaccharide, GLPH-1

Poster Title: Experimental Animal Nutrition (Poster Number: C304)

About Functional Foods

Functional foods are foods and beverages with claimed health benefits based on scientific evidence. The field of functional foods is an emerging field in the food science industry and is composed of the foods that contain scientifically validated ingredients that provide a health benefit above the benefit of the food itself. The market is growing exponentially with a projected growth from $25 billion in 2006 to $39 billion by 2011.

About Gourmetceuticals

Gourmetceuticals, LLC is a research-based culinary technology company that markets organically derived and scientifically tested ingredients for use in foods and beverages. Its ingredients, GLPH-1(TM) and PPL-240(TM), can transform human and veterinary products into gourmet functional foods and are FDA approved for human and animal consumption, GRAS affirmed, kosher and meet current Good Manufacturing Practices (cGMP) as outlined by the FDA. GLPH-1 is a polysaccharide extract from botanical yeast that promotes immune health and PPL-240 is an antioxidant derived from a South American fern that has been shown clinically to reduce damage from UVA and UVB rays. Both ingredients have been subject to more than 20 clinical trials that evaluated and supported their safety and effectiveness in humans and animals. For more information, visit the Company Web site at http://www.gourmetceuticals.com.


'/>"/>
SOURCE Gourmetceuticals, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
2. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
3. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
4. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
5. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
6. AtriCure to Present at Roth Capital Partners 2007 New York Conference
7. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
8. MDS to Present at Thomas Weisel Partners Healthcare Conference
9. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
10. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... ... ... According to recent statistics, there are nearly half a million physical ... Each physical therapy professional and every clinic has a duty to perform at the ... a competitive industry is also essential. The solution that many physical therapy leaders turn ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... FDAI, DAHC, CDC, has joined the Fire Door Solutions’ team. Keith will ... fire door and frame in-field re-labeling. He will be instrumental in developing ...
(Date:5/31/2016)... ... ... More than 80 representatives of the Hepatitis B Foundation , Hepatitis ... an event on National Hepatitis Testing Day outside of Philadelphia City Hall to raise ... of liver cancer. , Foundation leaders and the citywide coalition they created, Hep B ...
(Date:5/31/2016)... ... May 31, 2016 , ... ... Healthconnect’s (Healthconnect) regional health information exchange, which enables physicians at SJMC’s two hospital ... patients from other participating organizations in the exchange. SJMC’s membership in the health ...
(Date:5/31/2016)... Beach, Florida (PRWEB) , ... May 31, 2016 ... ... to Jay Butch of CertainTeed Corporation, he knew it was something that contractors ... as state-of-the-art and cutting-edge as it gets,” says Butch, CertainTeed’s Director of Contractor ...
Breaking Medicine News(10 mins):
(Date:5/30/2016)... -- On 28 May, 194 Member States made ... the 69 th World Health Assembly, governments unanimously voted ... the greatest global commitment in viral hepatitis to date. ... and C by 2030 and includes a set of prevention ... by 65% and increase treatment to 80%, saving 7.1 million ...
(Date:5/30/2016)... 2016 LifeScienceIndustryResearch.com adds "Ulcerative ... report with comprehensive information on the therapeutic development ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Ulcerative ...
(Date:5/27/2016)... -- A new study highlights the necessity of health literacy within the technology advancement of ... of Radiology , a majority of oncology patients undergo imaging screenings without understanding the ... ... ... Medical Diagnostic Imaging Ampronix ...
Breaking Medicine Technology: